PrimeCell Advanced Therapy is focused on contributing our knowledge and resources in regenerative medicine and somatocellular therapy to help patients and societies fighting COVID-19-associated ARDS. Our ATMP product (Remescor®) could significantly improve critical care management of COVID-19-associated ARDS and resource planning.
